{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T20:35:32Z","timestamp":1782592532851,"version":"3.54.5"},"reference-count":55,"publisher":"Elsevier BV","issue":"43","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82002147"],"award-info":[{"award-number":["82002147"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82073618"],"award-info":[{"award-number":["82073618"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82273695"],"award-info":[{"award-number":["82273695"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372229"],"award-info":[{"award-number":["82372229"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2019M662543"],"award-info":[{"award-number":["2019M662543"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.vaccine.2023.08.083","type":"journal-article","created":{"date-parts":[[2023,9,15]],"date-time":"2023-09-15T09:08:24Z","timestamp":1694768904000},"page":"6470-6482","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Active inoculation with an inactivated Coxsackievirus A2 vaccine induces neutralizing antibodies and protects mice against lethal infection"],"prefix":"10.1016","volume":"41","author":[{"given":"Yuexia","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangquan","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peiyu","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuaiyin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5084-5859","authenticated-orcid":false,"given":"Yuefei","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangcai","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.08.083_b0005","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s10096-018-3206-x","article-title":"Hand, foot and mouth disease: current knowledge on clinical manifestations, epidemiology, aetiology and prevention","volume":"37","author":"Esposito","year":"2018","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.083_b0010","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s12250-019-00169-2","article-title":"National Epidemiology and Evolutionary History of Four Hand, Foot and Mouth Disease-Related Enteroviruses in China from 2008 to 2016","volume":"35","author":"Fu","year":"2020","journal-title":"Virol Sin"},{"key":"10.1016\/j.vaccine.2023.08.083_b0015","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s12519-021-00451-y","article-title":"Molecular epidemiology of coxsackievirus A16 circulating in children in Beijing, China from 2010 to 2019","volume":"17","author":"Hu","year":"2021","journal-title":"World J Pediatr"},{"key":"10.1016\/j.vaccine.2023.08.083_b0020","article-title":"Molecular Epidemiology and Clinical Features of Enteroviruses-Associated Hand, Foot, and Mouth Disease and Herpangina Outbreak in Zunyi, China, 2019","volume":"8","author":"Ai","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/j.vaccine.2023.08.083_b0025","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.3201\/eid2709.204915","article-title":"Seroprevalence and Virologic Surveillance of Enterovirus 71 and Coxsackievirus A6, United Kingdom, 2006\u20132017","volume":"27","author":"Kamau","year":"2021","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.083_b0030","doi-asserted-by":"crossref","first-page":"e84233","DOI":"10.1371\/journal.pone.0084233","article-title":"Prevalence of multiple enteroviruses associated with hand, foot, and mouth disease in Shijiazhuang City, Hebei province, China: outbreaks of coxsackieviruses a10 and b3","volume":"9","author":"Tian","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.08.083_b0035","doi-asserted-by":"crossref","first-page":"529","DOI":"10.3181\/00379727-90-22088","article-title":"Recently classified types of Coxsackie virus, group A; behavior in tissue culture","volume":"90","author":"Sickles","year":"1955","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/j.vaccine.2023.08.083_b0040","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1177\/0009922820910822","article-title":"The Epidemiological and Clinical Characteristics of Hand, Foot, and Mouth Disease in Hangzhou, China, 2016 to 2018","volume":"59","author":"Wang","year":"2020","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/j.vaccine.2023.08.083_b0045","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1007\/s00705-020-04734-z","article-title":"Molecular epidemiology of enteroviruses associated with severe hand, foot and mouth disease in Shenzhen, China, 2014\u20132018","volume":"165","author":"Chen","year":"2020","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2023.08.083_b0050","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s13337-017-0366-8","article-title":"High prevalence of coxsackievirus A2 in children with herpangina in Thailand in 2015","volume":"28","author":"Chansaenroj","year":"2017","journal-title":"Virusdisease"},{"key":"10.1016\/j.vaccine.2023.08.083_b0055","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jcv.2015.11.024","article-title":"Enterovirus infections in hospitals of Ile de France region over 2013","volume":"74","author":"Molet","year":"2016","journal-title":"J Clin Virol"},{"key":"10.1016\/j.vaccine.2023.08.083_b0060","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1007\/s00705-020-04536-3","article-title":"Genetic characterization of VP1 of coxsackieviruses A2, A4, and A10 associated with hand, foot, and mouth disease in Vietnam in 2012\u20132017: endemic circulation and emergence of new HFMD-causing lineages","volume":"165","author":"Hoa-Tran","year":"2020","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2023.08.083_b0065","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1080\/22221751.2020.1850181","article-title":"Molecular characterization and epidemiological aspects of non-polio enteroviruses isolated from acute flaccid paralysis in Brazil: a historical series (2005\u20132017)","volume":"9","author":"Sousa","year":"2020","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2023.08.083_b0070","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1186\/1743-422X-9-205","article-title":"Enteroviruses isolated from herpangina and hand-foot-and-mouth disease in Korean children","volume":"9","author":"Park","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2023.08.083_b0075","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2021.658093","article-title":"Neonatal Murine Model of Coxsackievirus A2 Infection for the Evaluation of Antiviral Therapeutics and Vaccination","volume":"12","author":"Ji","year":"2021","journal-title":"Front Microbiol"},{"key":"10.1016\/j.vaccine.2023.08.083_b0080","doi-asserted-by":"crossref","unstructured":"Standaert B, Rappuoli R. Towards a more comprehensive approach for a total economic assessment of vaccines?: 1. The building blocks for a health economic assessment of vaccination. J Mark Access Health Policy. 2017;5:1335162.","DOI":"10.1080\/20016689.2017.1335162"},{"key":"10.1016\/j.vaccine.2023.08.083_b0085","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1007\/s12250-020-00294-3","article-title":"From Monovalent to Multivalent Vaccines, the Exploration for Potential Preventive Strategies Against Hand, Foot, and Mouth Disease (HFMD)","volume":"36","author":"He","year":"2021","journal-title":"Virol Sin"},{"key":"10.1016\/j.vaccine.2023.08.083_b0090","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/22221751.2021.1899772","article-title":"The epidemiological characteristics of enterovirus infection before and after the use of enterovirus 71 inactivated vaccine in Kunming","volume":"10","author":"Jiang","year":"2021","journal-title":"China. Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2023.08.083_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24010169","article-title":"Hand-Foot-and-Mouth Disease-Associated Enterovirus and the Development of Multivalent HFMD Vaccines","volume":"24","author":"Zhang","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2023.08.083_b0100","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1080\/22221751.2022.2093132","article-title":"Development and evaluation of an inactivated coxsackievirus A16 vaccine in gerbils","volume":"11","author":"Sun","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2023.08.083_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2020.198067","article-title":"Muscle destruction caused by coxsackievirus A10 in gerbils: Construction of a novel animal model for antiviral evaluation","volume":"286","author":"Chen","year":"2020","journal-title":"Virus Res"},{"key":"10.1016\/j.vaccine.2023.08.083_b0110","article-title":"A 10-Day-Old Murine Model of Coxsackievirus A6 Infection for the Evaluation of Vaccines and Antiviral Drugs","volume":"12","author":"Jiang","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.08.083_b0115","doi-asserted-by":"crossref","first-page":"4716","DOI":"10.1016\/j.vaccine.2022.06.021","article-title":"Efficacy of Coxsackievirus A2 vaccine candidates correlating to humoral immunity in mice challenged with a mouse-adapted strain","volume":"40","author":"Hu","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.083_b0120","doi-asserted-by":"crossref","unstructured":"Jin Y, Sun T, Zhou G, Li D, Chen S, Zhang W, et al. Pathogenesis Study of Enterovirus 71 Using a Novel Human SCARB2 Knock-In Mouse Model. mSphere. 2021;6.","DOI":"10.1128\/mSphere.01048-20"},{"key":"10.1016\/j.vaccine.2023.08.083_b0125","doi-asserted-by":"crossref","first-page":"e0204359","DOI":"10.1371\/journal.pone.0204359","article-title":"Persistent circulation of genotype D coxsackievirus A2 in mainland of China since 2008","volume":"13","author":"Yang","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.08.083_b0130","article-title":"Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection","volume":"91","author":"Zhang","year":"2017","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.08.083_b0135","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1186\/s12985-017-0911-5","article-title":"Pulmonary edema following central nervous system lesions induced by a non- mouse-adapted EV71 strain in neonatal BALB\/c mice","volume":"14","author":"Jin","year":"2017","journal-title":"Virol J"},{"key":"10.1016\/j.vaccine.2023.08.083_b0140","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1080\/22221751.2022.2119166","article-title":"A mouse-adapted CVA6 strain exhibits neurotropism and triggers systemic manifestations in a novel murine model","volume":"11","author":"Li","year":"2022","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2023.08.083_b0145","doi-asserted-by":"crossref","first-page":"e0178259","DOI":"10.1371\/journal.pone.0178259","article-title":"An inactivated hand-foot-and-mouth disease vaccine using the enterovirus 71 (C4a) strain isolated from a Korean patient induces a strong immunogenic response in mice","volume":"12","author":"In","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.08.083_b0150","doi-asserted-by":"crossref","first-page":"e0230721","DOI":"10.1128\/spectrum.02307-21","article-title":"The CXCL10\/CXCR3 Axis Promotes Disease Pathogenesis in Mice upon CVA2 Infection","volume":"10","author":"Liang","year":"2022","journal-title":"Microbiol Spectr"},{"issue":"Suppl 4","key":"10.1016\/j.vaccine.2023.08.083_b0155","doi-asserted-by":"crossref","first-page":"D80","DOI":"10.1016\/j.vaccine.2011.10.005","article-title":"The global polio eradication initiative: lessons learned and prospects for success","volume":"29","author":"Aylward","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.083_b0160","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.vaccine.2016.12.055","article-title":"Immunogenicity differences of a 15-valent pneumococcal polysaccharide conjugate vaccine (PCV15) based on vaccine dose, route of immunization and mouse strain","volume":"35","author":"Caro-Aguilar","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.083_b0165","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.612747","article-title":"Optimize Prime\/Boost Vaccine Strategies: Trained Immunity as a New Player in the Game","volume":"12","author":"Palgen","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.vaccine.2023.08.083_b0170","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1002\/eji.1830250329","article-title":"Interleukin-12 profoundly up-regulates the synthesis of antigen-specific complement-fixing IgG2a, IgG2b and IgG3 antibody subclasses in vivo","volume":"25","author":"Germann","year":"1995","journal-title":"Eur J Immunol"},{"key":"10.1016\/j.vaccine.2023.08.083_b0175","doi-asserted-by":"crossref","first-page":"e64024","DOI":"10.1371\/journal.pone.0064024","article-title":"Human IgG subclasses against enterovirus Type 71: neutralization versus antibody dependent enhancement of infection","volume":"8","author":"Cao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.08.083_b0180","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20061256","article-title":"Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease","volume":"20","author":"Anasir","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2023.08.083_b0185","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.immuni.2017.07.009","article-title":"Fcgamma Receptor Function and the Design of Vaccination Strategies","volume":"47","author":"Bournazos","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.vaccine.2023.08.083_b0190","doi-asserted-by":"crossref","unstructured":"Zou J, Xie X, Liu M, Shi PY, Ren P. Neutralization Titers in Vaccinated Patients with SARS-CoV-2 Delta Breakthrough Infections. mBio. 2022;13:e0199622.","DOI":"10.1128\/mbio.01996-22"},{"key":"10.1016\/j.vaccine.2023.08.083_b0195","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1080\/22221751.2021.1906755","article-title":"Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model","volume":"10","author":"Qian","year":"2021","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2023.08.083_b0200","doi-asserted-by":"crossref","first-page":"e2147022","DOI":"10.1080\/22221751.2022.2147022","article-title":"Humoral and cellular immunogenicity and efficacy of a coxsackievirus A10 vaccine in mice","volume":"12","author":"An","year":"2023","journal-title":"Emerg Microbes Infect"},{"key":"10.1016\/j.vaccine.2023.08.083_b0205","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01743-20","article-title":"Efficacy of Coxsackievirus A5 Vaccine Candidates in an Actively Immunized Mouse Model","volume":"95","author":"Jin","year":"2021","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2023.08.083_b0210","doi-asserted-by":"crossref","first-page":"280","DOI":"10.4049\/jimmunol.2200143","article-title":"Comparison of Neutralizing Antibody Response Kinetics in Patients with Hand, Foot, and Mouth Disease Caused by Coxsackievirus A16 or Enterovirus A71: A Longitudinal Cohort Study of Chinese Children, 2017\u20132019","volume":"209","author":"Zhou","year":"2022","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2023.08.083_b0215","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.3201\/eid2307.170310","article-title":"MERS-CoV Antibody Responses 1 Year after Symptom Onset, South Korea, 2015","volume":"23","author":"Choe","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.083_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103078","article-title":"Enterovirus genomic load and disease severity among children hospitalised with hand, foot and mouth disease","volume":"62","author":"Song","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/j.vaccine.2023.08.083_b0225","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12929-020-00650-1","article-title":"Cardiopulmonary failure in children infected with Enterovirus A71","volume":"27","author":"Hsia","year":"2020","journal-title":"J Biomed Sci"},{"key":"10.1016\/j.vaccine.2023.08.083_b0230","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S1473-3099(10)70194-8","article-title":"Virology, epidemiology, pathogenesis, and control of enterovirus 71","volume":"10","author":"Solomon","year":"2010","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.083_b0235","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.chom.2022.04.007","article-title":"Maternal immune protection against infectious diseases","volume":"30","author":"Langel","year":"2022","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.vaccine.2023.08.083_b0240","first-page":"311","article-title":"Seroprevalence of Bordetella pertussis among vaccinated and unvaccinated pregnant women and newborn infants in a university hospital of Buenos Aires","volume":"115","author":"Bosch","year":"2017","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/j.vaccine.2023.08.083_b0245","doi-asserted-by":"crossref","first-page":"5173","DOI":"10.1016\/j.vaccine.2018.07.011","article-title":"Pertussis Immunisation in Pregnancy Safety (PIPS) Study: A retrospective cohort study of safety outcomes in pregnant women vaccinated with Tdap vaccine","volume":"36","author":"Griffin","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.083_b0250","doi-asserted-by":"crossref","first-page":"5787","DOI":"10.1016\/j.vaccine.2014.08.038","article-title":"The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels - a prospective study","volume":"32","author":"Abu Raya","year":"2014","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.083_b0255","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1172\/JCI29466","article-title":"Antigen-specific immune responses to influenza vaccine in utero","volume":"117","author":"Rastogi","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/j.vaccine.2023.08.083_b0260","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S1473-3099(20)30480-1","article-title":"The transfer and decay of maternal antibodies against enterovirus A71, and dynamics of antibodies due to later natural infections in Chinese infants: a longitudinal, paired mother-neonate cohort study","volume":"21","author":"Wei","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.083_b0265","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1097\/AOG.0000000000003161","article-title":"Maternal Immunization","volume":"133","author":"Munoz","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.vaccine.2023.08.083_b0270","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.vaccine.2018.12.005","article-title":"Would immunization be the same without cross-reactivity?","volume":"37","author":"Vojtek","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.083_b0275","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1128\/JCM.00007-11","article-title":"Complete genome analysis of coxsackievirus A2, A4, A5, and A10 strains isolated from hand, foot, and mouth disease patients in China revealing frequent recombination of human enterovirus A","volume":"49","author":"Hu","year":"2011","journal-title":"J Clin Microbiol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23010496?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23010496?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:31:48Z","timestamp":1759404708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23010496"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":55,"journal-issue":{"issue":"43","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0264410X23010496"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.083","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Active inoculation with an inactivated Coxsackievirus A2 vaccine induces neutralizing antibodies and protects mice against lethal infection","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.083","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}